Gene · 10
Papers3,552
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
581 to 600 of 3,552
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A Multi-Marker Test for Analyzing Paired Genetic Data in Transplantation. | Front Genet | 2021 | 34721531 | PubTator, text mining | PubMed |
| Potential lncRNA Biomarkers for HBV-Related Hepatocellular Carcinoma Diagnosis Revealed by Analysis on Coexpression Network. | Biomed Res Int | 2021 | 34692847 | PubTator, text mining | PubMed |
| Is a high dose sufficient to achieve high isoniazid exposure in children affected by multidrug-resistant TB? | Int J Tuberc Lung Dis | 2021 | 34686227 | PubTator, text mining | PubMed |
| Characterisation and preliminary functional analysis of N-acetyltransferase 13 from Schistosoma japonicum. | BMC Vet Res | 2021 | 34686208 | PubTator, text mining | PubMed |
| The liver steatosis severity and lipid characteristics in primary biliary cholangitis. | BMC Gastroenterol | 2021 | 34686147 | PubTator, text mining | PubMed |
| Association of N-acetyltransferases 1 and 2 Polymorphisms with Susceptibility to Head and Neck Cancers-A Meta-Analysis, Meta-Regression, and Trial Sequential Analysis. | Medicina (Kaunas) | 2021 | 34684132 | PubTator, text mining | PubMed |
| Development of physiologically-based pharmacokinetic models for standard of care and newer tuberculosis drugs. | CPT Pharmacometrics Syst Pharmacol | 2021 | 34623770 | PubTator, text mining | PubMed |
| Downregulation of CYP2E1 is associated with poor prognosis and tumor progression of gliomas. | Cancer Med | 2021 | 34612013 | PubTator, text mining | PubMed |
| Next-Generation Intestinal Toxicity Model of Human Embryonic Stem Cell-Derived Enterocyte-Like Cells. | Front Vet Sci | 2021 | 34604364 | PubTator, text mining | PubMed |
| Diuretic Resistance Treated with Low-Dose Hydralazine: A Case Report and Review of the Literature. | Case Rep Nephrol Dial | 2021 | 34595213 | PubTator, text mining | PubMed |
| The estimated risk of SARS-CoV- 2 infection via cornea transplant in Canada. | Cell Tissue Bank | 2021 | 34591239 | PubTator, text mining | PubMed |
| Decreased mortality seen in rifampicin/multidrug-resistant tuberculous meningitis treated with linezolid in Shenzhen, China. | BMC Infect Dis | 2021 | 34583653 | PubTator, text mining | PubMed |
| Caffeine as a Factor Influencing the Functioning of the Human Body-Friend or Foe? | Nutrients | 2021 | 34578966 | PubTator, text mining | PubMed |
| Discrete Survival Model Analysis of Plasmodium falciparum Response to Artemisinin-Based Combination Therapies among Children in Regions of Varying Malaria Transmission in Cameroon. | Pathogens | 2021 | 34578139 | PubTator, text mining | PubMed |
| Pharmacogenomics Variability of Lipid-Lowering Therapies in Familial Hypercholesterolemia. | J Pers Med | 2021 | 34575654 | PubTator, text mining | PubMed |
| Maternal trichloroethylene exposure and metabolic gene polymorphisms may interact during fetal cardiovascular malformation. | Reprod Toxicol | 2021 | 34555461 | PubTator, text mining | PubMed |
| Research Progress of Pharmacogenomics in Drug-Induced Liver Injury. | Front Pharmacol | 2021 | 34552491 | PubTator, text mining | PubMed |
| Constructing xenobiotic maps of metabolism to predict enzymes catalyzing metabolites capable of binding to DNA. | BMC Bioinformatics | 2021 | 34548010 | PubTator, text mining | PubMed |
| Isonicotinylation is a histone mark induced by the anti-tuberculosis first-line drug isoniazid. | Nat Commun | 2021 | 34545082 | PubTator, text mining | PubMed |
| Using Isoniazid More Safely and More Effectively: The Time Is Now. | Am J Respir Crit Care Med | 2021 | 34543582 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10/papers?page=30